Trial · NCT06700187
Frequency of Interrupting Sitting and Cognitive Function
NCT06700187, Not applicable, Recruiting, Maastricht University Medical Center
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Frequency of Interrupting Sitting and Cognitive Function. Trials, record NCT06700187. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06700187
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Frequency of Interrupting Sitting and Cognitive Function
- NCT number
- NCT06700187
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 33 participants, estimated
- Lead sponsor
- Maastricht University Medical Center
- Conditions
- Sedentary Behaviors, Breaking Prolonged Sitting With Physical Activity
- Interventions
- Interrupting sitting with walking breaks
- First posted
- 2024-11-21
- Last updated
- 2026-01-14
Source ClinicalTrials.gov
Registered outcomes10
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Mental flexibility | baseline and 5 hours post baseline | It will be assessed using the computer-based Trial Making Test |
| Secondary | Interference | baseline and 5 hours post baseline | Interference is assessed by the computer-based Stroop task |
| Secondary | Memory | baseline and 5 hours post baseline | Memory is assessed by the computer-based n-Back Test |
| Secondary | Attention | baseline and 5 hours post baseline | Attention is assessed by the paper-based d2 attention Test |
| Secondary | Glucose metabolism | baseline, 30 minutes, 1 hour, 1.5 hour, 2 hour, 3 hour, 4 hour, and 5 hour post baseline | Concentration of plasma glucose will be tested. |
| Secondary | Glucose metabolism | baseline, 30 minutes, 1 hour, 1.5 hour, 2 hour, 3 hour, 4 hour, and 5 hour post baseline | Concentration of serum insulin will be tested. |
| Secondary | Serum brain-derived neurotrophic factor (BDNF) | baseline, 2 hour, 3 hour, and 5 hour post baseline | Concentration of serum BDNF, as one of the exploratory outcomes will be tested. |
| Secondary | Blood lipids | baseline, and 5 hours post baseline | As exploratory outcomes, concentration of serum total cholesterol (TC), and high-density lipoprotein cholesterol (HDL-C) will be tested. |
| Secondary | Serum triacylglycerol (TAG) | baseline, 30 minutes, 1 hour, 1.5 hour, 2 hour, 3 hour, 4 hour, and 5 hour post baseline | As another exploratory outcome, concentration of serum TAG will be tested. |
| Secondary | Mood | baseline and 5 hours post baseline | Short version of Profile of Mood States (POMS) questionnaire will be used to test mood. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers5
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests3
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| 1-Back Task | Secondary outcome | ConductCognition |
| 2-Back Task | Secondary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06700187
GET https://conductscience.org/api/trials/v1/NCT06700187/registered